https://www.selleckchem.com/pr....oducts/Vorinostat-sa
0008) indicating that the impact of steroids depended on the patient's NLR. In a subgroup analysis, only in patients with NLR less then 4 was there a significant difference in OS with upfront steroids (26.1 vs. 15.6 months, p = .032). The impact of steroids on the efficacy of ICI in patients with NSCLCBM is dependent on the patient's NLR underscoring its importance in these patients. Patients with a low NLR, steroid use decreases the efficacy of ICI. These results can inform clinicians about the impact of steroids in patients